Brief for Mon 28 Sep 2026

Not investment advice. This is a personal learning log. The authors are not SEBI-registered investment advisers or research analysts. Nothing here is a recommendation to buy or sell any security. Intraday levels are published only after the session has closed, as a record of what was tested. The portfolio is simulated, and past results don't predict future ones. Do your own research.

Intraday candidates for Mon 28 Sep 2026 (levels from Fri 25 Sep EOD — not live)

Market context (Fri 25 Sep): Nifty 50 closed 23,140.50 (+0.34% / +77 pts; Sensex 73,895.74). Session rebound after Thu sell-off, but week still down ~0.9% — 7th consecutive weekly loss. Bias for Mon: cautious; prefer stock-specific strength over index beta. (Sources: India Today / Moneycontrol / FinTech Edge, 25 Sep 2026)

Calendar: Mon 28 Sep is a trading day. Fri 2 Oct (Gandhi Jayanti) is closed (confirmed).

Only 2 names clear both quality + Fri EOD momentum with usable ~1% stops. Shortlist rejects: HINDZINC (fresh 52W low), OFSS (below 20/50-DMA, RSI~33–35, force-majeure drop), BSE (below 50/200-DMA), POLYCAB (below 50-DMA), SONACOMS/DLF (ROE <15%), MOTILALOFS (ROCE 12.7%), COALINDIA (50-DMA not rising; Fri vol ~0.4x 20d avg).

1) ZYDUSLIFE (NSE) — primary

Fundamental quality: ROE 21.2%, ROCE 21.1%; sales 3Y CAGR 16%, profit 5Y CAGR ~19%; promoter ~75%. Borrowings rose materially in FY26 (D/E still ~0.5 — manageable, watch). Source: Screener.in (as of 25 Sep close).

Technical setup (Fri 25 Sep EOD): Close 1,203.90 (O 1,185.50 / H 1,208.60 / L 1,182.40) — closed near high; 8-session win streak / at 52W high zone. Above rising 20-DMA ~1,145.6 and rising 50-DMA ~1,137.5; RSI(14) ~64–65; vol 19.9L vs ~20d avg ~12.1L (~1.6x). 20d RS vs Nifty ~+5 pp. Long buildup (OI +13.8%). Sources: Yahoo Finance India EOD; MarketsMojo / Strota / Screener charts.

Planned limit entry: 1,200 Stop (~1%): 1,188 Target (~1.5–2x risk): 1,218 – 1,224 Reward:risk: 1.5 : 1 to 2.0 : 1 Reason: Clean quality + Fri strength (near-high close, above-avg vol, rising 20/50-DMA, F&O long buildup). Levels planned from Fri close for Mon open limit — not a live signal. Cancel at open: Gap open ≥1,210 (chase past entry); or Nifty opens weak and ZYDUSLIFE fails to hold 1,195 in first 15–30 min; or opens ≤1,188 (stop already gone).

2) APOLLOHOSP (NSE) — secondary

Fundamental quality: ROE 21.2%, ROCE 17.4%; sales 3Y CAGR 15%, profit 5Y CAGR ~76%; Nifty 50 / F&O liquid. Debt elevated for a hospital (D/E ~0.9) but Screener flags steady growth; no governance red flag on checklist. Source: Screener.in (as of 25 Sep close).

Technical setup (Fri 25 Sep EOD): Close 8,889 (O 8,891 / H 8,934.50 / L 8,821.50) — held prior pullback, closed mid-upper range on above-avg volume. Above rising 20-DMA ~8,828 and rising 50-DMA ~8,839; RSI(14) ~55; vol 4.38L vs ~20d avg ~2.89L (~1.5x). 20d RS vs Nifty ~+4.5 pp. Sources: Yahoo Finance India EOD; Screener.in.

Planned limit entry: 8,880 Stop (~1%): 8,790 Target (~1.5–2x risk): 9,015 – 9,060 Reward:risk: 1.5 : 1 to 2.0 : 1 Reason: Quality large-cap health name holding above rising 20/50-DMA with Fri volume confirmation after Thu pullback; modest RS vs weak Nifty. Lower conviction than ZYDUSLIFE (flat Fri % change). Cancel at open: Gap open ≥8,950 (past useful limit); or fails 8,820 early; or Nifty opens sharply weak with private-hospital beta selling.

Desk note: Prefer ZYDUSLIFE if only one slot. Both are planned Fri-close levels for Mon limit-near-open; Real Stock Trader sizes / proposes Zerodha orders for the owner's explicit yes. No live data used.